397 related articles for article (PubMed ID: 28828688)
1. Nomograms predicting survival of patients with unresectable or metastatic gastric cancer who receive combination cytotoxic chemotherapy as first-line treatment.
Kim SY; Yoon MJ; Park YI; Kim MJ; Nam BH; Park SR
Gastric Cancer; 2018 May; 21(3):453-463. PubMed ID: 28828688
[TBL] [Abstract][Full Text] [Related]
2. Nomograms for predicting survival in patients with metastatic gastric adenocarcinoma who undergo palliative gastrectomy.
Ma T; Wu ZJ; Xu H; Wu CH; Xu J; Peng WR; Fan LL; Sun GP
BMC Cancer; 2019 Aug; 19(1):852. PubMed ID: 31462229
[TBL] [Abstract][Full Text] [Related]
3. Nomogram for predicting survival in patients with unresectable and/or metastatic urothelial cancer who are treated with cisplatin-based chemotherapy.
Galsky MD; Moshier E; Krege S; Lin CC; Hahn N; Ecke T; Sonpavde G; Godbold J; Oh WK; Bamias A
Cancer; 2013 Aug; 119(16):3012-9. PubMed ID: 23720216
[TBL] [Abstract][Full Text] [Related]
4. Nomogram for predicting the survival of gastric adenocarcinoma patients who receive surgery and chemotherapy.
Wang CY; Yang J; Zi H; Zheng ZL; Li BH; Wang Y; Ge Z; Jian GX; Lyu J; Li XD; Ren XQ
BMC Cancer; 2020 Jan; 20(1):10. PubMed ID: 31906882
[TBL] [Abstract][Full Text] [Related]
5. Nomogram-based Prediction of Overall Survival in Patients with Metastatic Urothelial Carcinoma Receiving First-line Platinum-based Chemotherapy: Retrospective International Study of Invasive/Advanced Cancer of the Urothelium (RISC).
Necchi A; Sonpavde G; Lo Vullo S; Giardiello D; Bamias A; Crabb SJ; Harshman LC; Bellmunt J; De Giorgi U; Sternberg CN; Cerbone L; Ladoire S; Wong YN; Yu EY; Chowdhury S; Niegisch G; Srinivas S; Vaishampayan UN; Pal SK; Agarwal N; Alva A; Baniel J; Golshayan AR; Morales-Barrera R; Bowles DW; Milowsky MI; Theodore C; Berthold DR; Daugaard G; Sridhar SS; Powles T; Rosenberg JE; Galsky MD; Mariani L;
Eur Urol; 2017 Feb; 71(2):281-289. PubMed ID: 27726966
[TBL] [Abstract][Full Text] [Related]
6. Performance of a nomogram predicting disease-specific survival after an R0 resection for gastric cancer in patients receiving postoperative chemoradiation therapy.
Dikken JL; Coit DG; Baser RE; Gönen M; Goodman KA; Brennan MF; Jansen EP; Boot H; van de Velde CJ; Cats A; Verheij M
Int J Radiat Oncol Biol Phys; 2014 Mar; 88(3):624-9. PubMed ID: 24411620
[TBL] [Abstract][Full Text] [Related]
7. Nomogram to predict survival of patients with advanced and metastatic pancreatic Cancer.
Deng GC; Lv Y; Yan H; Sun DC; Qu TT; Pan YT; Han QL; Dai GH
BMC Cancer; 2021 Nov; 21(1):1227. PubMed ID: 34781928
[TBL] [Abstract][Full Text] [Related]
8. A nomogram to predict overall survival and disease-free survival after curative resection of gastric adenocarcinoma.
Kim Y; Spolverato G; Ejaz A; Squires MH; Poultsides G; Fields RC; Bloomston M; Weber SM; Votanopoulos K; Acher AW; Jin LX; Hawkins WG; Schmidt C; Kooby D; Worhunsky D; Saunders N; Levine EA; Cho CS; Maithel SK; Pawlik TM
Ann Surg Oncol; 2015; 22(6):1828-35. PubMed ID: 25388061
[TBL] [Abstract][Full Text] [Related]
9. Development and external validation of a nomogram for overall survival after curative resection in serosa-negative, locally advanced gastric cancer.
Hirabayashi S; Kosugi S; Isobe Y; Nashimoto A; Oda I; Hayashi K; Miyashiro I; Tsujitani S; Kodera Y; Seto Y; Furukawa H; Ono H; Tanabe S; Kaminishi M; Nunobe S; Fukagawa T; Matsuo R; Nagai T; Katai H; Wakai T; Akazawa K
Ann Oncol; 2014 Jun; 25(6):1179-84. PubMed ID: 24669009
[TBL] [Abstract][Full Text] [Related]
10. Development and validation of a prognostic nomogram to predict survival in patients with advanced pancreatic cancer receiving second-line palliative chemotherapy.
Hsu CC; Liu KH; Chang PH; Chen PT; Hung CY; Hsueh SW; Yeh KY; Chen YY; Lu CH; Hung YS; Chou WC
J Gastroenterol Hepatol; 2020 Oct; 35(10):1694-1703. PubMed ID: 31711261
[TBL] [Abstract][Full Text] [Related]
11. Nomogram predicting long-term survival after d2 gastrectomy for gastric cancer.
Han DS; Suh YS; Kong SH; Lee HJ; Choi Y; Aikou S; Sano T; Park BJ; Kim WH; Yang HK
J Clin Oncol; 2012 Nov; 30(31):3834-40. PubMed ID: 23008291
[TBL] [Abstract][Full Text] [Related]
12. Nomogram for 5-year relapse-free survival of a patient with advanced gastric cancer after surgery.
Muneoka Y; Akazawa K; Ishikawa T; Ichikawa H; Nashimoto A; Yabusaki H; Tanaka N; Kosugi SI; Wakai T
Int J Surg; 2016 Nov; 35():153-159. PubMed ID: 27664559
[TBL] [Abstract][Full Text] [Related]
13. A novel nomogram individually predicting disease-specific survival after D2 gastrectomy for advanced gastric cancer.
Wang W; Sun Z; Deng JY; Qi XL; Feng XY; Fang C; Ma XH; Wang ZN; Liang H; Xu HM; Zhou ZW
Cancer Commun (Lond); 2018 May; 38(1):23. PubMed ID: 29764518
[TBL] [Abstract][Full Text] [Related]
14. The Efficacy of Adjuvant FOLFOX6 for Patients With Gastric Cancer after D2 Lymphadenectomy: A Propensity Score-matched Analysis.
Wang ZX; Yang XL; He MM; Wang F; Zhang DS; Li YH; Zhou ZW; Zhan YQ; Xu RH
Medicine (Baltimore); 2016 Apr; 95(16):e3214. PubMed ID: 27100411
[TBL] [Abstract][Full Text] [Related]
15. Survival nomogram for curatively resected Korean gastric cancer patients: multicenter retrospective analysis with external validation.
Eom BW; Ryu KW; Nam BH; Park Y; Lee HJ; Kim MC; Cho GS; Kim CY; Ryu SW; Shin DW; Hyung WJ; Lee JH
PLoS One; 2015; 10(2):e0119671. PubMed ID: 25723182
[TBL] [Abstract][Full Text] [Related]
16. Association of Adjuvant Chemotherapy With Survival in Patients With Stage II or III Gastric Cancer.
Jiang Y; Li T; Liang X; Hu Y; Huang L; Liao Z; Zhao L; Han Z; Zhu S; Wang M; Xu Y; Qi X; Liu H; Yang Y; Yu J; Liu W; Cai S; Li G
JAMA Surg; 2017 Jul; 152(7):e171087. PubMed ID: 28538950
[TBL] [Abstract][Full Text] [Related]
17. Development and external validation of two nomograms to predict overall survival and occurrence of distant metastases in adults after surgical resection of localised soft-tissue sarcomas of the extremities: a retrospective analysis.
Callegaro D; Miceli R; Bonvalot S; Ferguson P; Strauss DC; Levy A; Griffin A; Hayes AJ; Stacchiotti S; Pechoux CL; Smith MJ; Fiore M; Dei Tos AP; Smith HG; Mariani L; Wunder JS; Pollock RE; Casali PG; Gronchi A
Lancet Oncol; 2016 May; 17(5):671-80. PubMed ID: 27068860
[TBL] [Abstract][Full Text] [Related]
18. Nomogram-based prediction of survival in patients with advanced oesophagogastric adenocarcinoma receiving first-line chemotherapy: a multicenter prospective study in the era of trastuzumab.
Custodio A; Carmona-Bayonas A; Jiménez-Fonseca P; Sánchez ML; Viudez A; Hernández R; Cano JM; Echavarria I; Pericay C; Mangas M; Visa L; Buxo E; García T; Rodríguez Palomo A; Álvarez Manceñido F; Lacalle A; Macias I; Azkarate A; Ramchandani A; Fernández Montes A; López C; Longo F; Sánchez Bayona R; Limón ML; Díaz-Serrano A; Hurtado A; Madero R; Gómez C; Gallego J
Br J Cancer; 2017 Jun; 116(12):1526-1535. PubMed ID: 28463962
[TBL] [Abstract][Full Text] [Related]
19. Nomograms to predict pathologic complete response and metastasis-free survival after preoperative chemotherapy for breast cancer.
Rouzier R; Pusztai L; Delaloge S; Gonzalez-Angulo AM; Andre F; Hess KR; Buzdar AU; Garbay JR; Spielmann M; Mathieu MC; Symmans WF; Wagner P; Atallah D; Valero V; Berry DA; Hortobagyi GN
J Clin Oncol; 2005 Nov; 23(33):8331-9. PubMed ID: 16293864
[TBL] [Abstract][Full Text] [Related]
20. Chemoresponse after non-curative gastrectomy for M1 gastric cancer.
Shin HB; Lee SH; Son YG; Ryu SW; Sohn SS
World J Surg Oncol; 2015 Jan; 13():13. PubMed ID: 25634223
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]